Weiner; Warren S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Weiner; Warren S..The latest application filed is for "peptide inhibitors of focal adhesion kinase activity and uses thereof".
- Weiner; Warren S. - Phoenix AZ
- Weiner; Warren S. - Boston MA
- Weiner; Warren S. - Lawrence KS
- Weiner; Warren S. - Salt Lake City UT
| Patent | Date |
|---|---|
| Peptide Inhibitors Of Focal Adhesion Kinase Activity And Uses Thereof App 20220306692 - Marlowe; Timothy ; et al. | 2022-09-29 |
| Selective D3 Dopamine Receptor Agonists And Methods Of Their Use App 20210323941 - Sibley; David R. ; et al. | 2021-10-21 |
| Inhibitors Of The Mitf Molecular Pathway App 20170334842 - FALOON; Patrick ; et al. | 2017-11-23 |
| Inhibitors of the MITF molecular pathway Grant 9,745,261 - Faloon , et al. August 29, 2 | 2017-08-29 |
| Selective Efflux Inhibitors And Related Pharmaceutical Compositions And Methods Of Treatment App 20160244457 - Larson; Richard Smith ; et al. | 2016-08-25 |
| Inhibitors Of The Mitf Molecular Pathway App 20160130222 - FALOON; Patrick ; et al. | 2016-05-12 |
| Compounds for Alzheimer's disease Grant 9,216,966 - Gassman , et al. December 22, 2 | 2015-12-22 |
| Selective Efflux Inhibitors And Related Pharmaceutical Compositions And Methods Of Treatment App 20150197526 - Larson; Richard Smith ; et al. | 2015-07-16 |
| Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment Grant 9,056,111 - Larson , et al. June 16, 2 | 2015-06-16 |
| Compounds for Alzheimer's disease Grant 9,034,871 - Slade , et al. May 19, 2 | 2015-05-19 |
| Compounds For Alzheimer's Disease App 20130261118 - Gassman; Andrew D. ; et al. | 2013-10-03 |
| Compounds And Therapeutical Uses Thereof App 20130029942 - Anderson; Mark B. ; et al. | 2013-01-31 |
| Compounds and therapeutical use thereof Grant 8,309,562 - Anderson , et al. November 13, 2 | 2012-11-13 |
| Compounds For Alzheimer's Disease App 20120225873 - Slade; Rachel ; et al. | 2012-09-06 |
| Pyrrole derivatives as therapeutic compounds Grant 8,217,073 - Weiner , et al. July 10, 2 | 2012-07-10 |
| Pyrrole Derivatives As Therapeutic Compounds App 20100216862 - Weiner; Warren S. ; et al. | 2010-08-26 |
| Compounds For Alzheimber's Disease App 20100184975 - Slade; Rachel ; et al. | 2010-07-22 |
| Pyrrole derivatives as therapeutic compounds Grant 7,714,022 - Weiner , et al. May 11, 2 | 2010-05-11 |
| Compounds And Therapeutical Use Thereof App 20100069383 - ANDERSON; MARK B. ; et al. | 2010-03-18 |
| Pharmaceutical Compounds As Inhibitors Of Cell Proliferation And The Use Thereof App 20100068197 - ANDERSON; MARK B. ; et al. | 2010-03-18 |
| Compounds for alzheimer's disease Grant 7,678,823 - Slade , et al. March 16, 2 | 2010-03-16 |
| Pharmaceutical Compounds As Inhibitors Of Cell Proliferation And The Use Thereof App 20090280133 - Suzuki; Kazuyuki ; et al. | 2009-11-12 |
| Pharmaceutical Composition And Method App 20090155903 - Slade; Rachel M. ; et al. | 2009-06-18 |
| Compounds For Alzheimer's Disease App 20080249135 - Slade; Rachel ; et al. | 2008-10-09 |
| Pyrrole Derivatives As Therapeutic Compounds App 20080249158 - Weiner; Warren S. ; et al. | 2008-10-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 